Takayasu's arteritis with lung artery involvement study
Part of Heart & circulation, Immune system & allergy clinical trials.
This study looks at people with Takayasu's arteritis that also affects the lungs' blood vessels. Researchers want to understand the disease's behavior and outcomes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Takayasu's arteritis (a rare disease that causes inflammation of the large blood vessels).
- You have lung artery involvement from this condition, confirmed by a special CT scan or angiogram.
- Your hospitalization for this study must have occurred between January 2016 and December 2026.
- If you have lung artery narrowing from other causes (like other types of blood vessel disease, blood clots, or tumors), you cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies treatment for people with Takayasu arteritis when it affects the lung arteries. It may help reduce problems caused by narrowed or involved lung arteries.
This study collects information and blood samples (biomarkers) to better understand Takayasu arteritis and how active it is. It may help researchers find tests that support diagnosis and track disease activity.
This study collects information from people with rare types of pulmonary hypertension (high blood pressure in the lungs) and from healthy volunteers. It helps researchers better understand these conditions, especially using a special lung-heart test to confirm the diagnosis.
This trial is testing two new medications, vunakizumab and ivarmacitinib, to see if they are safe and effective at controlling active Takayasu's arteritis. These medicines work differently from your current treatment, so they might help reduce inflammation and prevent more damage to your blood vessels.
This study collects medical information from patients diagnosed with Takayasu arteritis, a rare disease affecting large blood vessels. By joining, you help researchers better understand this condition and improve care for future patients.
This study tests a new ultrasound scoring system to monitor disease activity in people with Takayasu arteritis. It aims to see if ultrasound can reliably track the disease, which might help guide treatment decisions.
Hear when a new Takayasu Arteritis With Pulmonary Artery Involvement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.